drugset / Trial / NCT00693225

Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

NCT00693225 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to determine the effect of morning versus bedtime administration of omeprazole/sodium bicarbonate (Zegerid) on endoscopic healing for patients with moderate or severe reflux esophagitis. Our hypothesis was that bedtime administration of Zegerid would be superior in healing esophagitis compared to morning administration prior to a meal.

Timeline

Start
2008-01
Primary completion
2010-12
Completion
2010-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Omeprazole/Sodium Bicarbonate AM Dose vs Omeprazole/Sodium Bicarbonate PM Dose; p = 1.0; Fisher Exact NCT00693225 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole/sodium bicarbonate Unknown 40 mg Oral

Indications